Brief: Dermapharm Holding: 9-Month Consolidated Revenue Up At EUR 734.3 Mln

Dermapharm Holding SE

16/11/2022 06:32

Nov 16 (Reuters) - DERMAPHARM HOLDING SE  DMPG.DE :
    * BOARD OF MANAGEMENT CONFIRMS OUTLOOK FOR 2022 OVERALL
    * 9-MONTH CONSOLIDATED REVENUE UP 9.6% TO EUR 734.3 MILLION
    * ADJUSTED CONSOLIDATED EBITDA RISES 5.1% TO EUR 239.4
MILLION
    * 9M ADJUSTED CONSOLIDATED EBITDA MARGIN: 32.6%
    * 9-MONTH ADJUSTED CONSOLIDATED EBITDA MARGIN: 32.6%
    * "PARALLEL IMPORT BUSINESS" SEGMENT REBOUNDS
    * BOARD OF MANAGEMENT CONFIRMS OUTLOOK FOR 2022 OVERALL
    * ALL THREE SEGMENTS RECORD REVENUE AND EARNINGS GROWTH

Source text for Eikon:  ID:nEQyG3hqa 
Further company coverage:  DMPG.DE 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))